US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CALCIMEDICA

1.57

-0.0800-4.85%

Volume:32.92K

Turnover:54.42K

Market Cap:21.94M

PE:-1.03

High:1.72

Open:1.69

Low:1.56

Close:1.65

Loading ...

Overview Company News Filings

CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates

THOMSON REUTERS

CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates

Calendar of U.S. Earnings Expected in the Week Ahead

CalciMedica Inc expected to post a loss of 35 cents a share - Earnings Preview

Calendar of U.S. Earnings Expected in the Week Ahead

Promising Phase 2 Results and Market Potential Drive Buy Rating for CalciMedica’s Auxora

Oppenheimer Keeps Their Buy Rating on CalciMedica (CALC)

CalciMedica Shares Drop After Securing New Credit Facility

BRIEF-CalciMedica Secures Credit Facility For Up To $32.5 Million

CalciMedica Secures Credit Facility for up to $32.5 Million

THOMSON REUTERS

CalciMedica Inc - Cash Position Expected to Fund Operations Into Mid-2026

THOMSON REUTERS

CalciMedica Secures Credit Facility for Up to $32.5 Million

CalciMedica Price Target Maintained With a $16.00/Share by HC Wainwright & Co.

CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference

CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference

CalciMedica to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

BRIEF-CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors

CalciMedica Announces Board Changes and New Appointment

CalciMedica Announces Appointment of DR. Alan Glicklich to Board of Directors

THOMSON REUTERS

Press Release: CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CALC/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CALC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CALC\",,,,,undefined,":{"symbol":"CALC","market":"US","secType":"STK","nameCN":"CALCIMEDICA","latestPrice":1.57,"timestamp":1750881600000,"preClose":1.65,"halted":0,"volume":32919,"delay":0,"floatShares":5784814,"shares":13971990,"eps":-1.530615,"marketStatus":"Not Yet Opened","change":-0.08,"latestTime":"06-25 16:00:00 EDT","open":1.69,"high":1.72,"low":1.56,"amount":54423.1887,"amplitude":0.09697,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.530615,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750924800000},"marketStatusCode":0,"adr":0,"listingDate":1601006400000,"exchange":"NASDAQ","adjPreClose":1.65,"preHourTrading":{"tag":"盘前","latestPrice":1.6,"preClose":1.65,"latestTime":"08:00 EDT","volume":2195,"amount":3549.7197579999997,"timestamp":1750852805634},"volumeRatio":1.496971},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CALC\",,,,,undefined,":{"symbol":"CALC","floatShares":5784814,"roa":"-59.39%","roe":"-134.15%","lyrEps":-1.21822,"volumeRatio":1.496971,"shares":13971990,"dividePrice":0,"high":1.72,"amplitude":0.09697,"preClose":1.65,"low":1.56,"week52Low":1.43,"pbRate":"2.01","week52High":5.97,"institutionHeld":0,"latestPrice":1.57,"eps":-1.530615,"divideRate":0,"volume":32919,"delay":0,"ttmEps":-1.530615,"open":1.69,"prevYearClose":3.54,"prevWeekClose":1.64,"prevMonthClose":1.71,"prevQuarterClose":1.91,"fiveDayClose":1.69,"twentyDayClose":1.76,"sixtyDayClose":1.99},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CALC\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522375379","title":"CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2522375379","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522375379?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:00","pubTimestamp":1743073203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nTUAVBBBS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2522714803","title":"CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2522714803","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522714803?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:00","pubTimestamp":1743073200,"startTime":"0","endTime":"0","summary":"Enrollment ongoing in Phase 2KOURAGE trial of Auxora in acute kidney injury  and respiratory failure; data expected around the end of 2025. Post-hoc analysis of subset of patients with AKI in the Phase 2 CARDEA trial of Auxora in severe COVID-19 pneumonia showed a 62.7% relative reduction in mortality at day 30, which persisted through day 60, for patients treated with Auxora versus placebo. Cash position expected to fund operations into mid-2026. LA JOLLA, Calif., March 27, 2025 /PRNewswire/ -- CalciMedica Inc.  , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium  channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today reported financial results for the year ended December 31, 2024 and provided clinical and corporate updates.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/calcimedica-reports-2024-financial-results-110000200.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/calcimedica-reports-2024-financial-results-110000200.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","AP","LU0256331488.USD","BK4213","BK4007","APA","CALC","BK4585","BK4006"],"gpt_icon":0},{"id":"2522329609","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2522329609","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522329609?lang=en_us&edition=fundamental","pubTime":"2025-03-27 18:00","pubTimestamp":1743069600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·INmune Bio Inc.                                 4Q      (.55)  4:05 PM. ·TD SYNNEX Corp                                   1Q      2.91   8:05 AM","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYTX","SKYH","WGO","REKR","BHST","FBIO","PVLA","EDAP","PRGS","IKT","SDST","ADCT","SLRN","TLSI","CLSD","GWH","ANGO","FEMY","FTCI","CALC","DARE","GEVO","LULU","PVH","SPWH","PENG","BRZE","WBA","LNZA","TSAT","WKSP","BW","NCNO","RANI","MDAI","CRDL","FC","RLMD","AFMD","SGML","CELC","GOVX","BCAB","UNCY","NNOX","ATAI","BLRX","INR","NUTX","INMB"],"gpt_icon":0},{"id":"2521723367","title":"CalciMedica Inc  expected to post a loss of 35 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2521723367","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521723367?lang=en_us&edition=fundamental","pubTime":"2025-03-24 20:33","pubTimestamp":1742819586,"startTime":"0","endTime":"0","summary":"CalciMedica Inc  expected to post a loss of35cents a share - Earnings Preview CalciMedica Inc CALC.OQ CALC.O is expected to show no change in quarterly revenue when it reports  results on March 26 (es","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nL5N3Q70XO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC"],"gpt_icon":0},{"id":"2521714099","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2521714099","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521714099?lang=en_us&edition=fundamental","pubTime":"2025-03-24 18:00","pubTimestamp":1742810400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Comp de San Bas                                  4Q       .36       AMC. ·Oklo Inc. Class A                               4Q      (.07)      AMC. ·Core & Main Inc.                                 4Q       .36       BMO. ·McCormick & Co                                 1Q       .64   6:30 AM","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABL","CNXC","NUTX","EDAP","THRD","CRMD","WGO","BEEM","SKYX","TEN","WBA","GRDN","IOBT","SLRN","GOVX","ACRV","MDAI","AFMD","LPTX","OBIO","KBH","BCAB","SDST","FBIO","PDSB","CALC","UNCY","CLSD","DLTR","CHWY","RVPH","MKC","CDLR","PAYX","SCS","ALUR","WOOF","RLMD","ANTX","SURG","IVA","IKT","ZURA","XFOR","MLKN","DERM","CTAS","MREO","KOD","PAYS"],"gpt_icon":0},{"id":"2517270178","title":"Promising Phase 2 Results and Market Potential Drive Buy Rating for CalciMedica’s Auxora","url":"https://stock-news.laohu8.com/highlight/detail?id=2517270178","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517270178?lang=en_us&edition=fundamental","pubTime":"2025-03-07 14:55","pubTimestamp":1741330540,"startTime":"0","endTime":"0","summary":"CalciMedica (CALC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on March 4. Analyst Joseph Pantginis fr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-phase-2-results-and-market-potential-drive-buy-rating-for-calcimedicas-auxora?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-phase-2-results-and-market-potential-drive-buy-rating-for-calcimedicas-auxora?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2517577661","title":"Oppenheimer Keeps Their Buy Rating on CalciMedica (CALC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517577661","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517577661?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:26","pubTimestamp":1741267583,"startTime":"0","endTime":"0","summary":"In a report released today, Leland Gershell from Oppenheimer reiterated a Buy rating on CalciMedica (CALC – Research Report), with a price target o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oppenheimer-keeps-their-buy-rating-on-calcimedica-calc?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oppenheimer-keeps-their-buy-rating-on-calcimedica-calc?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CALC","OPY"],"gpt_icon":0},{"id":"2517472559","title":"CalciMedica Shares Drop After Securing New Credit Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2517472559","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517472559?lang=en_us&edition=fundamental","pubTime":"2025-03-06 01:47","pubTimestamp":1741196820,"startTime":"0","endTime":"0","summary":"CalciMedica shares were down 5%, to $2.16, after the company said it has entered into a credit facility with Avenue Venture Opportunities Fund II, a fund of Avenue Capital Group, providing up to $32.5 million.The biopharmaceutical company said proceeds from the facility are intended to support the continued development of its product pipeline.The credit agreement, which has a term of 3 1/2 years, includes an initial tranche of $10 million fully funded at close and additional tranches of up to $22.5 million available to the company subject to certain milestones.There is no minimum cash requirement, nor other financial covenants, in the agreement. With the proceeds from the first tranche of this facility, CalciMedica's cash position is expected to fund current operations into the middle of 2026.CalciMedica shares hit their 52-week low of $1.86 Tuesday, and are down 53% in the past 12 months.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2517162119","title":"BRIEF-CalciMedica Secures Credit Facility For Up To $32.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2517162119","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517162119?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:44","pubTimestamp":1741178698,"startTime":"0","endTime":"0","summary":"BRIEF-CalciMedica Secures Credit Facility For Up To $32.5 MillionMarch 5 (Reuters) - CalciMedica CALC.O:CALCIMEDICA SECURES CREDIT FACILITY FOR UP TO $32.5 MILLIONCALCIMEDICA INC - CASH POSITION EXPEC","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nTUA2QGBLB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2517991395","title":"CalciMedica Secures Credit Facility for up to $32.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2517991395","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517991395?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:00","pubTimestamp":1741176006,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nTUA2QGBLB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2517791301","title":"CalciMedica Inc - Cash Position Expected to Fund Operations Into Mid-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2517791301","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517791301?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:00","pubTimestamp":1741176006,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nTUA2QGBLB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2517491913","title":"CalciMedica Secures Credit Facility for Up to $32.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2517491913","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517491913?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:00","pubTimestamp":1741176000,"startTime":"0","endTime":"0","summary":"$10 million funded at close extends cash runway into mid-2026. LA JOLLA, Calif., March 5, 2025 /PRNewswire/ -- CalciMedica Inc.  , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium  channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that the Company has entered into a credit facility with Avenue Venture Opportunities Fund II, L.P., a fund of Avenue Capital Group, providing up to $32.5 million. Proceeds from the facility are intended to support the continued development of the Company's product pipeline.\"Avenue welcomes this opportunity to support CalciMedica in its mission to deliver treatments to patients with high unmet need,\" said Chad Norman, Senior Portfolio Manager of Avenue Venture Opportunities Fund. \"We appreciate the potential of its lead pipeline candidate, Auxora, to treat acute inflammatory and immunologic diseases and look forward to its continued progress in cli","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/calcimedica-secures-credit-facility-32-120000258.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/calcimedica-secures-credit-facility-32-120000258.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AP","BK4007","BK4006","CALC"],"gpt_icon":0},{"id":"2516679565","title":"CalciMedica Price Target Maintained With a $16.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2516679565","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516679565?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:29","pubTimestamp":1741094940,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CALC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 04, 2025 08:29 ET (13:29 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC"],"gpt_icon":0},{"id":"2516620121","title":"CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2516620121","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516620121?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:00","pubTimestamp":1741089600,"startTime":"0","endTime":"0","summary":"LA JOLLA, Calif., March 4, 2025 /PRNewswire/ -- CalciMedica Inc.  , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium  channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announcedthat Sudarshan Hebbar, M.D., Chief Medical Officer of CalciMedica, delivered a plenary presentation at the 30th International Acute Kidney Injury and Continuous Renal Replacement Therapy Conference  on March 3, 2025 in San Diego, CA. The presentation outlined the role of CRAC channels in acute kidney injury  pathophysiology and included new data highlighting the potential of CalciMedica's lead product candidate, Auxora, in AKI. CalciMedica is currently conducting a Phase 2 trial of Auxora in patients with Stage 2 or Stage 3 AKI and acute hypoxemic respiratory failure, which is expected to read out in 2025.In clinical trial biomarker studies, CARDEA patients who received Auxora versus placebo had","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/calcimedica-presents-aki-data-post-120000286.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/calcimedica-presents-aki-data-post-120000286.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4535","CALC","AP","BK4139","BK4212","BK4585","BK4007","BNTX","BK4551","BK4588","POST","BK4006","BK4548","BK4568"],"gpt_icon":0},{"id":"2512064881","title":"CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2512064881","media":"PR Newswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512064881?lang=en_us&edition=fundamental","pubTime":"2025-02-19 20:00","pubTimestamp":1739966400,"startTime":"0","endTime":"0","summary":"LA JOLLA, Calif., Feb. 19, 2025 /PRNewswire/ -- CalciMedica Inc.  , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium  channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced a plenary presentation at the 30th International Acute Kidney Injury and Continuous Renal Replacement Therapy Conference  being held March 3-6, 2025 in San Diego, CA.Session Title: Plenary 2: Bench to Bedside: Translating Discoveries to Clinical Care. Session Date and Time: Monday, March 3, 10:35-10:55 a.m. PT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/calcimedica-announces-upcoming-plenary-presentation-120000500.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/calcimedica-announces-upcoming-plenary-presentation-120000500.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4006","CALC","AP","BK4007"],"gpt_icon":0},{"id":"2508178010","title":"CalciMedica to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2508178010","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508178010?lang=en_us&edition=fundamental","pubTime":"2025-02-04 05:05","pubTimestamp":1738616700,"startTime":"0","endTime":"0","summary":"LA JOLLA, Calif., Feb. 3, 2025 /PRNewswire/ -- CalciMedica Inc.  , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium  channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that Rachel Leheny, Ph.D., Chief Executive Officer, will present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on Wednesday, February 12, 2025, at 8:00 a.m. ET.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/calcimedica-participate-oppenheimer-35th-annual-210500130.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/calcimedica-participate-oppenheimer-35th-annual-210500130.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4137","CALC","OPY","BK4007","BK4127","AP","HCSG","BK4006"],"gpt_icon":0},{"id":"2503852257","title":"BRIEF-CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2503852257","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503852257?lang=en_us&edition=fundamental","pubTime":"2025-01-14 20:40","pubTimestamp":1736858409,"startTime":"0","endTime":"0","summary":"BRIEF-CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of DirectorsJan 14 (Reuters) - CalciMedica Inc CALC.O:CALCIMEDICA ANNOUNCES APPOINTMENT OF DR. ALAN GLICKLICH TO BOARD OF DIRECTORSSource text: ID:nPn4YWh6laFurther company coverage: CALC.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250114:nTUA7NR9WH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2503524718","title":"CalciMedica Announces Board Changes and New Appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=2503524718","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503524718?lang=en_us&edition=fundamental","pubTime":"2025-01-14 20:30","pubTimestamp":1736857832,"startTime":"0","endTime":"0","summary":"CalciMedica ( ($CALC) ) has issued an announcement. On January 10, 2025, Eric Bjerkholt resigned from the board of directors and audit committee of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/calcimedica-announces-board-changes-and-new-appointment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/calcimedica-announces-board-changes-and-new-appointment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2503529065","title":"CalciMedica Announces Appointment of DR. Alan Glicklich to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2503529065","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503529065?lang=en_us&edition=fundamental","pubTime":"2025-01-14 20:00","pubTimestamp":1736856007,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250114:nTUA7NR9WH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2503881521","title":"Press Release: CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2503881521","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503881521?lang=en_us&edition=fundamental","pubTime":"2025-01-14 20:00","pubTimestamp":1736856000,"startTime":"0","endTime":"0","summary":"LA JOLLA, Calif., Jan. 14, 2025 /PRNewswire/ -- CalciMedica Inc.  , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium  channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced the appointment of Alan Glicklich, M.D. to the Company's Board of Directors effective on January 15, 2025. Dr. Glicklich has more than 20 years of experience in the biotechnology industry and currently serves as Chief Medical Officer of Nuvig Therapeutics.\"I am impressed by the data from the multiple Phase 2 clinical trials with CalciMedica's drug, Auxora, which has shown a variety of benefits, including a substantial reduction in organ failure, in acute inflammatory diseases. These benefits are important to patients in CalciMedica's lead indications of acute pancreatitis and acute kidney injury, in which organ failure is a significant cause of mortality and morbidity, no dis","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4099","BK4585","BK4588","BK4007","03160","BK4555","AP","TM","BK4006"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":40}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CALC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-14","symbol":"CALC","fiscalQuarterEnding":"2025/03","expectedEps":-0.43,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"pre","actualEps":-0.36},{"market":"US","date":"2025-03-27","symbol":"CALC","fiscalQuarterEnding":"2024/12","expectedEps":-0.48,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"pre","actualEps":-0.34},{"market":"US","date":"2024-11-13","symbol":"CALC","fiscalQuarterEnding":"2024/09","expectedEps":-0.61,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.5},{"market":"US","date":"2024-08-12","symbol":"CALC","fiscalQuarterEnding":"2024/06","expectedEps":-0.55,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723435200000,"reportTimeType":"post","actualEps":-0.52},{"market":"US","date":"2024-05-13","symbol":"CALC","fiscalQuarterEnding":"2024/03","expectedEps":-0.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715572800000,"reportTimeType":"post","actualEps":-0.43}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CALC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CALC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1734494400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CALC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CALC","date":"2025-06-24","current":-1.140148,"percent":0.954023,"low":-4.525842,"twenty":-3.51173,"median":-2.490404,"eighty":-1.495804,"high":-0.644854,"avg":-2.485917,"sd":0.980249,"marketCap":21516864},"quantilePoints":[{"date":"2024-01-05","current":-0.71129,"twenty":-0.71129,"median":-0.71129,"eighty":-0.71129,"marketCap":20480891},{"date":"2024-01-12","current":-0.644854,"twenty":-0.706809,"median":-0.663373,"eighty":-0.661399,"marketCap":18567932},{"date":"2024-01-19","current":-0.842346,"twenty":-0.707705,"median":-0.673245,"eighty":-0.662978,"marketCap":24254510},{"date":"2024-01-26","current":-1.017241,"twenty":-1.012132,"median":-0.706809,"eighty":-0.663373,"marketCap":29290430},{"date":"2024-02-02","current":-2.31259,"twenty":-1.35801,"median":-0.893146,"eighty":-0.671271,"marketCap":66588713},{"date":"2024-02-09","current":-1.906022,"twenty":-2.088582,"median":-1.017241,"eighty":-0.673245,"marketCap":54881987},{"date":"2024-02-16","current":-1.682223,"twenty":-2.119115,"median":-1.116267,"eighty":-0.690619,"marketCap":48437918},{"date":"2024-02-23","current":-1.643058,"twenty":-2.095833,"median":-1.634666,"eighty":-0.702071,"marketCap":47310206},{"date":"2024-03-01","current":-1.633733,"twenty":-2.020905,"median":-1.643058,"eighty":-0.709498,"marketCap":47041703},{"date":"2024-03-08","current":-1.652383,"twenty":-1.962717,"median":-1.659843,"eighty":-0.789924,"marketCap":47578709},{"date":"2024-03-15","current":-1.626273,"twenty":-1.923926,"median":-1.652383,"eighty":-0.903305,"marketCap":46826901},{"date":"2024-03-22","current":-1.428584,"twenty":-1.903784,"median":-1.64026,"eighty":-0.984091,"marketCap":41134640},{"date":"2024-03-28","current":-1.309808,"twenty":-1.864992,"median":-1.631159,"eighty":-1.013409,"marketCap":45001081},{"date":"2024-04-05","current":-1.359825,"twenty":-1.759493,"median":-1.626273,"eighty":-1.046819,"marketCap":46719500},{"date":"2024-04-12","current":-1.378581,"twenty":-1.683991,"median":-1.551673,"eighty":-1.099979,"marketCap":47363907},{"date":"2024-04-19","current":-1.25354,"twenty":-1.680731,"median":-1.469614,"eighty":-1.115647,"marketCap":43067861},{"date":"2024-04-26","current":-1.653672,"twenty":-1.680731,"median":-1.452232,"eighty":-1.163031,"marketCap":56815208},{"date":"2024-05-03","current":-1.87562,"twenty":-1.717206,"median":-1.540483,"eighty":-1.238535,"marketCap":64440690},{"date":"2024-05-10","current":-1.766209,"twenty":-1.764959,"median":-1.622543,"eighty":-1.25479,"marketCap":60681649},{"date":"2024-05-17","current":-3.903797,"twenty":-1.803163,"median":-1.628585,"eighty":-1.259167,"marketCap":58318824},{"date":"2024-05-24","current":-3.709686,"twenty":-1.90453,"median":-1.64026,"eighty":-1.263536,"marketCap":55418993},{"date":"2024-05-31","current":-4.076341,"twenty":-2.061189,"median":-1.652383,"eighty":-1.269686,"marketCap":60896452},{"date":"2024-06-07","current":-3.763144,"twenty":-2.28275,"median":-1.667303,"eighty":-1.292545,"marketCap":56217609},{"date":"2024-06-14","current":-3.626433,"twenty":-2.775108,"median":-1.674763,"eighty":-1.30043,"marketCap":54175287},{"date":"2024-06-21","current":-3.741558,"twenty":-3.626433,"median":-1.678493,"eighty":-1.306682,"marketCap":55895138},{"date":"2024-06-28","current":-2.266521,"twenty":-3.626433,"median":-1.678493,"eighty":-1.308558,"marketCap":33859554},{"date":"2024-07-05","current":-3.0652,"twenty":-3.626433,"median":-1.678493,"eighty":-1.309808,"marketCap":45791016},{"date":"2024-07-12","current":-3.396184,"twenty":-3.511308,"median":-1.683696,"eighty":-1.342725,"marketCap":50735586},{"date":"2024-07-15","current":-3.518504,"twenty":-3.517065,"median":-1.685169,"eighty":-1.342739,"marketCap":52562927},{"date":"2024-08-02","current":-3.223823,"twenty":-3.515626,"median":-1.694429,"eighty":-1.342753,"marketCap":48160698},{"date":"2024-08-09","current":-3.346156,"twenty":-3.502674,"median":-1.717881,"eighty":-1.345855,"marketCap":49988225},{"date":"2024-08-16","current":-3.501123,"twenty":-3.583261,"median":-1.750157,"eighty":-1.351697,"marketCap":44075639},{"date":"2024-08-23","current":-3.569438,"twenty":-3.582315,"median":-1.766209,"eighty":-1.354811,"marketCap":44935652},{"date":"2024-08-30","current":-3.67191,"twenty":-3.613882,"median":-1.801693,"eighty":-1.356667,"marketCap":46225670},{"date":"2024-09-06","current":-4.397752,"twenty":-3.637946,"median":-1.869368,"eighty":-1.357299,"marketCap":55363303},{"date":"2024-09-13","current":-3.552359,"twenty":-3.65203,"median":-1.906022,"eighty":-1.362326,"marketCap":44720648},{"date":"2024-09-20","current":-3.53528,"twenty":-3.640824,"median":-2.030976,"eighty":-1.373579,"marketCap":44505645},{"date":"2024-09-27","current":-3.859775,"twenty":-3.700214,"median":-2.125233,"eighty":-1.378581,"marketCap":48590705},{"date":"2024-10-04","current":-3.740224,"twenty":-3.708962,"median":-2.289556,"eighty":-1.380457,"marketCap":47085683},{"date":"2024-10-11","current":-3.371069,"twenty":-3.708962,"median":-2.722888,"eighty":-1.392648,"marketCap":42438390},{"date":"2024-10-18","current":-3.381146,"twenty":-3.700214,"median":-2.935837,"eighty":-1.41484,"marketCap":42565242},{"date":"2024-10-25","current":-3.53528,"twenty":-3.675822,"median":-3.058004,"eighty":-1.429837,"marketCap":44505645},{"date":"2024-10-31","current":-4.098876,"twenty":-3.6768,"median":-3.0652,"eighty":-1.43485,"marketCap":51600748},{"date":"2024-11-08","current":-3.744979,"twenty":-3.72195,"median":-3.072551,"eighty":-1.469614,"marketCap":47145546},{"date":"2024-11-15","current":-3.340773,"twenty":-3.734279,"median":-3.223823,"eighty":-1.536753,"marketCap":45394425},{"date":"2024-11-22","current":-3.420079,"twenty":-3.72195,"median":-3.270562,"eighty":-1.540483,"marketCap":46472038},{"date":"2024-11-29","current":-3.423065,"twenty":-3.714694,"median":-3.298285,"eighty":-1.558387,"marketCap":46512613},{"date":"2024-12-06","current":-2.966657,"twenty":-3.710325,"median":-3.295449,"eighty":-1.607623,"marketCap":40310931},{"date":"2024-12-13","current":-2.768218,"twenty":-3.706791,"median":-3.249448,"eighty":-1.624781,"marketCap":37614548},{"date":"2024-12-20","current":-2.748374,"twenty":-3.682653,"median":-3.194715,"eighty":-1.626273,"marketCap":37344910},{"date":"2024-12-27","current":-2.986501,"twenty":-3.673866,"median":-3.079903,"eighty":-1.62766,"marketCap":40580570},{"date":"2025-01-03","current":-3.264315,"twenty":-3.665078,"median":-3.095642,"eighty":-1.630644,"marketCap":44355506},{"date":"2025-01-10","current":-2.976579,"twenty":-3.653123,"median":-3.165095,"eighty":-1.634479,"marketCap":40445751},{"date":"2025-01-17","current":-3.145251,"twenty":-3.645198,"median":-3.087772,"eighty":-1.638582,"marketCap":42737676},{"date":"2025-01-24","current":-2.867437,"twenty":-3.640824,"median":-3.065538,"eighty":-1.643058,"marketCap":38962740},{"date":"2025-01-31","current":-2.52017,"twenty":-3.640824,"median":-3.058004,"eighty":-1.652383,"marketCap":34244069},{"date":"2025-02-07","current":-2.688843,"twenty":-3.640824,"median":-3.04842,"eighty":-1.652383,"marketCap":36535995},{"date":"2025-02-14","current":-2.649155,"twenty":-3.63798,"median":-3.022334,"eighty":-1.653672,"marketCap":35996718},{"date":"2025-02-21","current":-2.420951,"twenty":-3.628742,"median":-2.996423,"eighty":-1.664577,"marketCap":32895877},{"date":"2025-02-28","current":-2.2622,"twenty":-3.626433,"median":-2.986501,"eighty":-1.670287,"marketCap":30738770},{"date":"2025-03-07","current":-2.182824,"twenty":-3.621826,"median":-2.966657,"eighty":-1.674017,"marketCap":29660217},{"date":"2025-03-14","current":-1.885166,"twenty":-3.613842,"median":-2.897203,"eighty":-1.674763,"marketCap":25615642},{"date":"2025-03-21","current":-2.083605,"twenty":-3.598472,"median":-2.84934,"eighty":-1.677747,"marketCap":28312025},{"date":"2025-03-28","current":-2.053839,"twenty":-3.588224,"median":-2.832711,"eighty":-1.678493,"marketCap":27907568},{"date":"2025-04-04","current":-1.800869,"twenty":-3.578114,"median":-2.788062,"eighty":-1.678493,"marketCap":24671908},{"date":"2025-04-11","current":-1.456441,"twenty":-3.570753,"median":-2.763257,"eighty":-1.678493,"marketCap":19953237},{"date":"2025-04-17","current":-1.515486,"twenty":-3.564314,"median":-2.743413,"eighty":-1.673271,"marketCap":20762152},{"date":"2025-04-25","current":-1.500724,"twenty":-3.555775,"median":-2.72853,"eighty":-1.652383,"marketCap":20559923},{"date":"2025-05-02","current":-1.525326,"twenty":-3.542112,"median":-2.713647,"eighty":-1.631674,"marketCap":20896971},{"date":"2025-05-09","current":-2.027208,"twenty":-3.53528,"median":-2.688843,"eighty":-1.635971,"marketCap":27772749},{"date":"2025-05-16","current":-1.385911,"twenty":-3.53528,"median":-2.683882,"eighty":-1.635971,"marketCap":26154918},{"date":"2025-05-23","current":-1.266008,"twenty":-3.530157,"median":-2.649155,"eighty":-1.623289,"marketCap":23892102},{"date":"2025-05-30","current":-1.292809,"twenty":-3.523446,"median":-2.629311,"eighty":-1.56753,"marketCap":24397888},{"date":"2025-06-06","current":-1.243723,"twenty":-3.518383,"median":-2.599038,"eighty":-1.538245,"marketCap":23471546},{"date":"2025-06-13","current":-1.295622,"twenty":-3.515866,"median":-2.540014,"eighty":-1.518241,"marketCap":24450982},{"date":"2025-06-20","current":-1.251201,"twenty":-3.512152,"median":-2.500326,"eighty":-1.501708,"marketCap":23612663},{"date":"2025-06-24","current":-1.140148,"twenty":-3.51173,"median":-2.490404,"eighty":-1.495804,"marketCap":21516864}],"updateTime":1750919669355}}}